We found a positive trend in the pooled estimate of six studies reporting on short-term mortality toward treatment with levosimendan (RR 0.69, 95% CI 0.47–1.00, low-level of evidence).
← all excerpts
Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
1
—
—